Emerging microbial epidemics occur unexpectedly and require brisk action in order to stop the disease from spreading. The most recent outbreak of SARS-CoV-2 in China, MERS coronavirus in Saudi Arabia and the Ebola virus epidemic in West Africa stressed the need for rapid communication to the public and the critical importance of developing diagnostics, vaccines and antiviral drugs as quickly as possible.
Our research focuses on emerging infectious diseases in human and animals. The aim of our research group is to accelerate biomedical research on emerging infections and aid in preparedness for emerging infectious diseases in the future.